Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for the "Cerebrospinal Fluid/ Urine Total Protein Assay Kit".
Konica Minolta Biological Co., Ltd. (002022.SZ) announced that the company recently received the "Medical Device... issued by the Shanghai Food and Drug Administration.
Shanghai Kehua Bio-engineering (002022.SZ) announced that the company has recently received the "Medical Device Registration Certificate" (in vitro diagnostic reagent) issued by the Shanghai Food and Drug Administration. The product is named "Cerebrospinal Fluid/Urinary Total Protein Measurement Test Kit (Ortho-Tolidine Red Method)". This reagent kit is used by medical institutions for in vitro quantitative determination of the total protein content in human cerebrospinal fluid or urine, for auxiliary diagnostic purposes.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
